FLT3 inhibition in acute myeloid leukaemia

被引：10
|
作者：
Daver, Naval [1 ]
Kantarjian, Hagop [1 ]
机构：
[1] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 08期
关键词：
MUTATIONS; THERAPY;
D O I：
10.1016/S1470-2045(17)30509-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：988 / 989
页数：2
相关论文
共 50 条
  • [41] Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy
    Zhang, Weiguo
    Yu, Guopan
    Zhang, Hongying
    Basyal, Mahesh
    Ly, Charlie
    Yuan, Bin
    Ruvolo, Vivian
    Piya, Sujan
    Bhattacharya, Seemana
    Zhang, Qi
    Borthakur, Gautam
    Battula, Venkata L.
    Konopleva, Marina
    Rice, William G.
    Andreeff, Michael
    HAEMATOLOGICA, 2023, 108 (06) : 1500 - 1514
  • [42] Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD+ acute myeloid leukemia
    Li, Dan
    Li, Tongjuan
    Shang, Zhen
    Zhao, Lei
    Xu, Qian
    Tan, Jiaqi
    Qin, Yun
    Zhang, Yuanyuan
    Cao, Yang
    Wang, Na
    Huang, Liang
    Zhu, Xiaojian
    Zhou, Kuangguo
    Chen, Liting
    Li, Chunrui
    Xie, Ting
    Yang, Yi
    Wang, Jue
    Zhou, Jianfeng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [43] FLT3 Inhibition as Therapy in Acute Myeloid Leukemia: A Record of Trials and Tribulations
    Fathi, Amir T.
    Chabner, Bruce A.
    ONCOLOGIST, 2011, 16 (08): : 1162 - 1174
  • [44] Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia
    Gregory, Mark A.
    Nemkov, Travis
    Reisz, Julie A.
    Zaberezhnyy, Vadym
    Hansen, Kirk C.
    D'Alessandro, Angelo
    DeGregori, James
    EXPERIMENTAL HEMATOLOGY, 2018, 58 : 52 - 58
  • [45] MIDOSTAURIN - THE FIRST TARGETED THERAPY DRUG FOR PATIENTS WITH ACUTE MYELOID LEUKAEMIA WITH FLT3 MUTATION
    Nowicka, Aneta
    Szalek, Edyta
    Gil, Lidia
    Sima, Martin
    Karbownik, Agnieszka
    ACTA POLONIAE PHARMACEUTICA, 2022, 79 (06): : 777 - 784
  • [46] FLT3 internal tandem duplication as a marker for minimal residual disease in acute myeloid leukaemia
    Hooper, R
    Austin, SJ
    Walsh, V
    Holt, D
    Mills, KI
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 33 - 33
  • [47] Incidence and clinical significance of FLT3 internal tandem duplications in acute myeloid leukaemia.
    Bown, N
    Powell, H
    Curtis, A
    Taylor, P
    JOURNAL OF MEDICAL GENETICS, 2004, 41 : S22 - S22
  • [48] A Novel Combination Regimen of BET and FLT3 Inhibition for FLT3-ITD Acute Myeloid Leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Ben
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Bollag, Gideon
    Levis, Mark J.
    BLOOD, 2019, 134
  • [49] A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Benjamin
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Hernandez, Daniela
    Rajkhowa, Trivikram
    Bollag, Gideon
    Levis, Mark
    HAEMATOLOGICA, 2021, 106 (04) : 1022 - 1033
  • [50] Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
    Jensen, Christopher E.
    Montgomery, Nathan D.
    Galeotti, Jonathan
    Foster, Matthew C.
    Zeidner, Joshua F.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (24) : 6079 - 6082
12345